Tritium labelling of the GLP-1 analogue liraglutide
✍ Scribed by Uffe S. Larsen; Heidi B. Hansen; Anne-Mette Dahl; Lone Sørensen; Jesper B. Kristensen
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- French
- Weight
- 78 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Tyr 19 -3 H]Liraglutide was synthesised in only two steps using Liraglutide as starting material.
* [Pal-3 H]Liraglutide was synthesised in seven steps with tritium introduced in the final two steps.
📜 SIMILAR VOLUMES
## Abstract Arg^34^Lys^26^(__N__^ε^‐(γ‐L‐glutamyl(__N__^α^‐palmitoyl)))‐GLP‐1(7‐37) (NN2211) is currently in development as a diabetes type 2 drug. The fatty acid attached to the GLP‐1(7‐37) ensures a long and controlled duration of action. The synthesis of [^125^I]NN2211, [^127^I]NN2211 and [^14^C
## Abstract In order to complete our previous publications on pharmacokinetics, action mechanism and metabolism studies, the following new, tritium‐labelled derivatives of Halidor have been prepared: 1‐benzyl ‐1‐(3′‐dimethylaminopropoxy) ‐3, 4, 5, 6‐^3^H‐cycloheptane fumarate, 1‐benzyl‐1‐(2′‐^3^H‐3
## Abstract Radiolabelled neurokinin‐1 (NK~1~) receptor antagonists **1b** and **2b** were required for __in vitro/in vivo__ characterization to support the development of **1a** and **2a** as fluorine‐18 labelled PET ligands. These tritium labelled compounds were synthesized from aryl iodide precu
## Abstract Two tritiated derivatives of Dmt^1^‐endomorphin 2 (Dmt^1^‐EM2) were prepared by the catalytic tritiodehalogenation of 3′,5′‐diiodo‐Dmt^1^‐EM2 and the saturation of ^3,4^ΔPro^2^‐Dmt^1^‐EM2, resulting in [3′,5′‐^3^H~2~]Dmt^1^‐EM2 and [^3^H~2~]Pro^2^‐Dmt^1^‐EM2 with specific activities of